Harmony Biosciences Inc. (HRMY)
NASDAQ: HRMY
· Real-Time Price · USD
31.60
-0.46 (-1.43%)
At close: Jun 25, 2025, 3:59 PM
32.38
2.47%
After-hours: Jun 25, 2025, 06:10 PM EDT
-1.43% (1D)
| Bid | 31.06 |
| Market Cap | 1.81B |
| Revenue (ttm) | 744.85M |
| Net Income (ttm) | 152.72M |
| EPS (ttm) | 2.62 |
| PE Ratio (ttm) | 12.06 |
| Forward PE | 8 |
| Analyst | Buy |
| Ask | 33.69 |
| Volume | 303,559 |
| Avg. Volume (20D) | 684,309 |
| Open | 32.23 |
| Previous Close | 32.06 |
| Day's Range | 31.25 - 32.23 |
| 52-Week Range | 26.47 - 41.61 |
| Beta | 0.87 |
About HRMY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HRMY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HRMY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Harmony Biosciences Inc. is scheduled to release its earnings on Aug 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-9.64%
Harmony Biosciences shares are trading lower after...
Unlock content with
Pro Subscription
7 months ago
-18.53%
Harmony Biosciences shares are trading lower after the company announced a public offering of up to 8 million shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings.
1 month ago · seekingalpha.com
Harmony Biosciences Holdings, Inc. (HRMY) Q1 2025 Earnings Call TranscriptHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q1 2025 Earnings Call May 6, 2025 8:30 AM ET Company Participants Brennan Doyle - Head, Investor Relations Jeffrey Dayno - President and Chief Executi...
